Partner, Ballard Spahr
Scott D. Marty focuses on various aspects of biotechnology patent prosecution and patent litigation, including post-grant proceedings under the AIA. He is the leader of the patent group’s biotechnology practice team, and a member of the pharmaceutical practice team. Dr. Marty has experience in all aspects of domestic and international patent prosecution, client counseling, prelitigation analysis and litigation relating to the biotechnical, chemical and pharmaceutical fields. He also has experience working with clients in reviewing, analyzing, and evaluating intellectual property-based issues as well as performing and providing detailed financial analysis to provide a well-rounded picture of opportunities for evaluating the overall portfolio.